Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03HAW
|
|||
| Former ID |
DIB004905
|
|||
| Drug Name |
HemaMax
|
|||
| Synonyms |
NMIL12-1; Recombinant human IL-12 (radiation sickness/thrombocytopenia/hematopoietic stem cell transplant), Neumedicines
Click to Show/Hide
|
|||
| Indication | Myelodysplastic syndrome [ICD-11: 2A37; ICD-9: 238.7] | Phase 2 | [1] | |
| Company |
Neumedicines Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02343133) Safety Study of HemaMax (rHuIL-12) to Treat Acute Radiation Syndrome. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.